The Department of Health and Human Services Food and Drug Administration awarded a definitive contract to Deloitte Consulting LLP, doing business as Deloitte, to implement the SHIELD-Harmonized Laboratory Data Standards in 6 active healthcare institutions. The contract has a potential value of $918,947.49 and was awarded on a labor hours pricing basis. No set-aside was utilized. The contract is focused on implementing data standards to support the FDA's mission. Key subcontractors include the...
This is a fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian agency, to the Association of Public Health Laboratories, Inc. (APHL) for $581,600.00. The contract, which has no set-aside designation, is for the implementation of the electronic laboratory reporting (ELR) requirements under Section 18115 of the CARES Act related to COVID-19 testing. APHL, a non-profit organization representing state and local public health laboratories, will provide access to its...
This contract award to the Association of Public Health Laboratories, Inc. (APHL) is a $9,086,592 firm-fixed-price definitive contract from the National Institutes of Health's National Heart Lung and Blood Institute. The contract involves the development of a system to allow individuals to voluntarily report over-the-counter COVID-19 test results to federal and state public health agencies. This will help public health experts monitor virus spread and better target response efforts through...
This is a firm-fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian federal agency, to the Association of Public Health Laboratories, Inc. (APHL), a non-profit organization. The $51,200 contract is for the FY 2025 Electronic Lab Reporting Association of Public Labs (AIMS) project, under OPID 525-142 and CAN J94PYIT. The contract has an ultimate completion date of December 31, 2025 and was awarded on February 5, 2025. This contract does not have a set-aside...
<p>This is a $9,671,431.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Safe Health Systems, Inc., a self-certified small disadvantaged business. The contract is for stimulating innovation in clinical evaluations and personalized medicine to improve product development and patient outcome. The contract has no set-aside designation and has an ultimate completion date of March 27, 2026.</p>
The Department of Health and Human Services' Food and Drug Administration has awarded a firm fixed price purchase order valued at thirty-five thousand dollars to Health Level Seven International Inc. As a prime contractor, HL7 will provide membership services to the agency to support cross-agency coordination and standards development activities. Specifically, the objective of this task order is for HL7 to obtain membership in its organization for FDA and regulated industry stakeholders. This...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Laboratory Corporation Of America Holdings, a global life sciences leader, for $115,000 to perform high-resolution, gene-based HLA typing of 1,000 patient samples. The requirement is to support the FDA's Center for Biologics Evaluation and Research (CBER) hemophilia genetic project. This is an open competition contract, with no set-aside designation. The award...
The Department of Veterans Affairs (VA) awarded a $3,160,191.80 firm-fixed-price purchase order contract to the Association of Public Health Laboratories, Inc. (APHL), a non-profit organization, to provide COVID-19 data reporting services. The contract does not have a set-aside designation. APHL, which represents state, local, and territorial public health laboratories, has expertise in developing electronic laboratory reporting systems and supporting pandemic response efforts. The...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Ihrc, Incorporated, a self-certified small disadvantaged business, woman-owned small business, and woman-owned business. The contract, valued at $170,046.00, is for the standardization and performance of Zika immuno-detection assays. This work supports the FDA's efforts to ensure the safety and efficacy of medical countermeasures for public health...
<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>